Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 16/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 11/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 5/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 13/20 | 0.51 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | CASP1 | P29466 | 4/20 | 0.42 |
| ▸ | CASP7 | P55210 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6028295 | 0.85 | ALDH1A1 (0.44) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6029117 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6029111 | 0.84 | ALDH1A1 (0.43) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL5809520 | 0.82 | GSK3B (0.48) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6029604 | 0.82 | ALDH1A1 (0.53) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6028404 | 0.81 | KDM4E (0.54) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6460768 | 0.81 | KDM4E (0.62) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6029626 | 0.80 | ALDH1A1 (0.53) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6029281 | 0.80 | ALDH1A1 (0.69) | ALDH1A1HSD17B10MAPTLMNANPSR1 | |
| SCHEMBL6028471 | 0.80 | KDM4E (0.47) | ALDH1A1HSD17B10MAPTLMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050203119-A1 | Dihydropyridine compounds for treating or preventing metabolic disorders | SYNTA PHARMACEUTICAL CORP. | 2005-09-15 | — | — | US | claimed |
| US-20050203119-A1 | Dihydropyridine compounds for treating or preventing metabolic disorders | SYNTA PHARMACEUTICAL CORP. | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203119-A1 | Dihydropyridine compounds for treating or preventing metabolic disorders | SLC5A2, SLC5A1, QDPR | ALDH1A1 416/4885HSD17B10 447/4885MAPT 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.